Consistent and durable reduction in death and myocardial infarction with abciximab during coronary intervention in acute coronary syndromes and stable angina: A pooled analysis from EPIC, EPILOG, and EPISTENT
Publication
, Journal Article
Roe, MT; Gum, PA; Booth, JE; Jia, G; Damaraju, L; Fitzpatrick, SE; Kereiakes, DJ; Tcheng, JE
Published in: CIRCULATION
November 2, 1999
Duke Scholars
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
November 2, 1999
Volume
100
Issue
18
Start / End Page
187 / 187
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Roe, M. T., Gum, P. A., Booth, J. E., Jia, G., Damaraju, L., Fitzpatrick, S. E., … Tcheng, J. E. (1999). Consistent and durable reduction in death and myocardial infarction with abciximab during coronary intervention in acute coronary syndromes and stable angina: A pooled analysis from EPIC, EPILOG, and EPISTENT. CIRCULATION, 100(18), 187–187.
Roe, M. T., P. A. Gum, J. E. Booth, G. Jia, L. Damaraju, S. E. Fitzpatrick, D. J. Kereiakes, and J. E. Tcheng. “Consistent and durable reduction in death and myocardial infarction with abciximab during coronary intervention in acute coronary syndromes and stable angina: A pooled analysis from EPIC, EPILOG, and EPISTENT.” CIRCULATION 100, no. 18 (November 2, 1999): 187–187.
Roe MT, Gum PA, Booth JE, Jia G, Damaraju L, Fitzpatrick SE, et al. Consistent and durable reduction in death and myocardial infarction with abciximab during coronary intervention in acute coronary syndromes and stable angina: A pooled analysis from EPIC, EPILOG, and EPISTENT. CIRCULATION. 1999 Nov 2;100(18):187–187.
Roe, M. T., et al. “Consistent and durable reduction in death and myocardial infarction with abciximab during coronary intervention in acute coronary syndromes and stable angina: A pooled analysis from EPIC, EPILOG, and EPISTENT.” CIRCULATION, vol. 100, no. 18, LIPPINCOTT WILLIAMS & WILKINS, Nov. 1999, pp. 187–187.
Roe MT, Gum PA, Booth JE, Jia G, Damaraju L, Fitzpatrick SE, Kereiakes DJ, Tcheng JE. Consistent and durable reduction in death and myocardial infarction with abciximab during coronary intervention in acute coronary syndromes and stable angina: A pooled analysis from EPIC, EPILOG, and EPISTENT. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 1999 Nov 2;100(18):187–187.
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
November 2, 1999
Volume
100
Issue
18
Start / End Page
187 / 187
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology